Skip to content
Tenfell
Awarded contract
Published 20 Mar 2017

Provision for HIV-1 LAg Avidity Kits

Public Health England · United Kingdom

Key facts

Contract value
£72,000
Awarded
28 Feb 2017
Contract starts
10 Mar 2017
Contract ends
09 Mar 2018
Procedure
Other -
Buyer type
Central government

Awarded to

SupplierValue
Sedia Biosciences Corporation£72,000

Description

Under PHE Microbiology Framework Lot 2 Development, Public Health England awarded contract for the provision of HIV-1 LAg Avidity kits to Sedia Biosciences Corporation.

These kits will be used as part of the PHE- NIS national surveillance of New HIV Diagnosis. This assay manufactured by Sedia has been developed by the US Centers for Disease Control and Prevention (CDC). As a result, the assay has been licensed to this company by the US CDC and it has undergone independent evaluation by the Consortium for the evaluation and performance of HIV Incidence assays.

Sedia Biosciences Corporation is the sole manufacturer of these kits being specifically manufactured for the purpose of identifying recent infection as it has been shown to have the lowest false recent rate and an acceptable mean duration of recency.

Categories (CPV)

Similar open tenders

About Public Health England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.